Skip to Content
 

News: February, 2019

New algorithm calculates drug synergy; initial tests involve melanoma, lung cancer

Monday, February 25th, 2019

Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren’t as effective as they could be. That could change with a new algorithm developed by a cross-disciplinary Vanderbilt University team for calculating drug synergy.

AHA statement supports vascular cardio-oncology

Monday, February 25th, 2019

The American Heart Association (AHA) has issued a scientific statement calling for the integration of cardio-oncology and vascular medicine to provide cancer patients and cancer survivors with optimal cardiovascular care.

Discovery points to new cancer immunotherapy option

Monday, February 25th, 2019

Researchers have discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.

The yin and yang of cell signaling

Thursday, February 14th, 2019

Changes in enzymes involved in lysophospholipid signaling can activate a pathway implicated in development of cancer, a recent study suggests.

Probing H. pylori cancer protein

Thursday, February 14th, 2019

A new study improves the understanding of how the stomach-dwelling bacterium Helicobacter pylori influences the risk of premalignant and malignant changes in the stomach.

Study finds patient messages help predict medication adherence

Monday, February 4th, 2019

Breast cancer patients who message their doctors about certain topics are more likely to discontinue hormone therapy than others, enabling doctors to better predict which patients are at risk of stopping their treatment early.

HPV Symposium Set For March 1

Monday, February 4th, 2019

Vanderbilt University Medical Center will host an educational symposium on human papillomavirus (HPV) and associated cancers on Friday, March 1.

Society of Urologic Oncology honors Barocas’ contributions

Monday, February 4th, 2019

Daniel Barocas, MD, MPH, associate professor of Urology, is being recognized with a national award from the Society of Urologic Oncology (SUO) for his efforts to develop urologic cancer quality measures.

Grant supports novel imaging initiative to enhance cancer care

Monday, February 4th, 2019

A Vanderbilt initiative to develop predictive imaging technologies that clinicians can use to better match patients with personalized care has received National Cancer Institute (NCI) funding.

Cell death pathway implicated in bone marrow failure

Monday, February 4th, 2019

Vanderbilt researchers have linked a specific form of programmed cell death to myelodysplastic syndrome, a type of bone marrow failure.